|
Shares
|
Description
|
Value (†)
|
|
Common Stocks — 97.9% of Net Assets
|
||
|
|
Australia — 4.9%
|
|
|
30,412
|
WiseTech Global Ltd.
|
$1,860,086
|
|
|
Belgium — 1.9%
|
|
|
11,571
|
Anheuser-Busch InBev SA
|
704,373
|
|
|
Brazil — 9.1%
|
|
|
447,628
|
Ambev SA, ADR
|
1,110,117
|
|
1,523
|
MercadoLibre, Inc.(a)
|
2,302,715
|
|
|
|
3,412,832
|
|
|
Canada — 3.2%
|
|
|
15,525
|
Shopify, Inc., Class A(a)
|
1,198,064
|
|
|
China — 21.3%
|
|
|
4,903
|
Alibaba Group Holding Ltd., ADR(b)
|
354,781
|
|
5,995
|
Baidu, Inc., ADR(a)(b)
|
631,154
|
|
83,600
|
Budweiser Brewing Co. APAC Ltd.
|
123,304
|
|
4,600
|
Kweichow Moutai Co. Ltd., Class A
|
1,079,112
|
|
5,191
|
NXP Semiconductors NV
|
1,286,174
|
|
34,800
|
Tencent Holdings Ltd.(b)
|
1,355,458
|
|
34,699
|
Trip.com Group Ltd., ADR(a)(b)
|
1,522,939
|
|
58,253
|
Vipshop Holdings Ltd., ADR(b)
|
964,087
|
|
17,584
|
Yum China Holdings, Inc.
|
699,667
|
|
|
|
8,016,676
|
|
|
Denmark — 8.1%
|
|
|
23,690
|
Novo Nordisk AS, Class B
|
3,038,796
|
|
|
France — 4.2%
|
|
|
3,566
|
EssilorLuxottica SA
|
806,670
|
|
9,081
|
Sodexo SA
|
778,453
|
|
|
|
1,585,123
|
|
|
Germany — 4.1%
|
|
|
7,982
|
SAP SE
|
1,554,246
|
|
|
Japan — 3.2%
|
|
|
34,800
|
FANUC Corp.
|
970,797
|
|
7,400
|
Unicharm Corp.
|
235,588
|
|
|
|
1,206,385
|
|
|
Macau — 0.7%
|
|
|
51,000
|
Galaxy Entertainment Group Ltd.
|
256,381
|
|
|
Netherlands — 7.7%
|
|
|
1,554
|
Adyen NV(a)
|
2,624,918
|
|
9,081
|
Pluxee NV(a)
|
268,439
|
|
|
|
2,893,357
|
|
Shares
|
Description
|
Value (†)
|
|
|
Switzerland — 4.5%
|
|
|
9,378
|
CRISPR Therapeutics AG(a)
|
$639,205
|
|
11,042
|
Novartis AG, (Registered)
|
1,069,510
|
|
|
|
1,708,715
|
|
|
United Kingdom — 4.8%
|
|
|
9,282
|
Diageo PLC
|
343,454
|
|
13,647
|
Reckitt Benckiser Group PLC
|
777,948
|
|
13,927
|
Unilever PLC
|
699,376
|
|
|
|
1,820,778
|
|
|
United States — 20.2%
|
|
|
13,382
|
ARM Holdings PLC, ADR(a)
|
1,672,616
|
|
10,558
|
Block, Inc.(a)
|
892,996
|
|
19,929
|
Doximity, Inc., Class A(a)
|
536,289
|
|
25,636
|
Experian PLC
|
1,117,036
|
|
9,802
|
Nestle SA, (Registered)
|
1,041,462
|
|
3,702
|
Roche Holding AG
|
945,190
|
|
8,039
|
Tesla, Inc.(a)
|
1,413,176
|
|
|
|
7,618,765
|
|
|
Total Common Stocks
(Identified Cost $36,087,114)
|
36,874,577
|
|
Principal
Amount
|
|
|
|
Short-Term Investments — 1.7%
|
||
|
$659,698
|
Tri-Party Repurchase Agreement with Fixed Income
Clearing Corporation, dated 3/28/2024 at 3.500% to be
repurchased at $659,955 on 4/01/2024 collateralized by
$725,400 U.S. Treasury Note, 0.750% due 4/30/2026
valued at $672,910 including accrued interest(c)
(Identified Cost $659,698)
|
659,698
|
|
|
Total Investments — 99.6%
(Identified Cost $36,746,812)
|
37,534,275
|
|
|
Other assets less liabilities — 0.4%
|
142,839
|
|
|
Net Assets — 100.0%
|
$37,677,114
|
|
(†)
|
Registered investment companies are required to value portfolio investments using an unadjusted, readily available market
quotation. The Fund obtains
readily available market quotations from independent pricing services. Fund investments for which readily available market
quotations are not available
are priced at fair value pursuant to the Fund's Valuation Procedures. The Board of Trustees has approved a valuation designee
who is subject to the
Board's oversight.
Unadjusted readily available market quotations that are utilized for exchange traded equity securities (including shares of
closed-end investment
companies and exchange-traded funds) include the last sale price quoted on the exchange where the security is traded most
extensively. Shares of open-
end investment companies are valued at net asset value ("NAV") per share.
Exchange traded equity securities for which there is no reported sale during the day are fair valued at the closing bid quotation
as reported by an
independent pricing service. Unlisted equity securities (except unlisted preferred equity securities) are fair valued at the
last sale price quoted in the
market where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as
reported by an independent
pricing service. If there is no last sale price or closing bid quotation available, unlisted equity securities will be fair
valued using evaluated bids furnished
by an independent pricing service, if available.
Debt securities and unlisted preferred equity securities are fair valued based on evaluated bids furnished to the Fund by
an independent pricing service or
bid prices obtained from broker-dealers. Broker-dealer bid prices may be used to fair value debt and unlisted equities where
an independent pricing
service is unable to price an investment or where an independent pricing service does not provide a reliable price for the
investment.
The Fund may also fair value investments in other circumstances such as when extraordinary events occur after the close of
a foreign market, but prior to
the close of the New York Stock Exchange. This may include situations relating to a single issuer (such as a declaration of
bankruptcy or a delisting of the
issuer's security from the primary market on which it has traded) as well as events affecting the securities markets in general
(such as market disruptions
or closings and significant fluctuations in U.S. and/or foreign markets). When fair valuing a Fund's investments, the valuation
designee may, among other
things, use modeling tools or other processes that may take into account factors such as issuer specific information, or other
related market activity
and/or information that occurred after the close of the foreign market but before the time the Fund's NAV is calculated. Fair
valuation by the Fund's
valuation designee may require subjective determinations about the value of the investment, and fair values used to determine
a Fund's NAV may differ
from quoted or published prices, or from prices that are used by others, for the same investments. In addition, the use of
fair value pricing may not always
result in adjustments to the prices of investments held by a Fund.
The books and records of the Fund are maintained in U.S. dollars. The values of securities, currencies and other assets and
liabilities denominated in
currencies other than U.S. dollars, if any, are translated into U.S. dollars based upon foreign exchange rates prevailing
at the end of the period.
|
|
(a)
|
Non-income producing security.
|
|
(b)
|
Security invests in variable interest entities based in China.
|
|
(c)
|
The Fund may enter into repurchase agreements, under the terms of a Master Repurchase Agreement, under which the Fund acquires
securities as
collateral and agrees to resell the securities at an agreed upon time and at an agreed upon price. It is the Fund's policy
that the market value of the
collateral for repurchase agreements be at least equal to 102% of the repurchase price, including interest. Certain repurchase
agreements are tri-party
arrangements whereby the collateral is held in a segregated account for the benefit of the Fund and on behalf of the counterparty.
Repurchase
agreements could involve certain risks in the event of default or insolvency of the counterparty, including possible delays
or restrictions upon the Fund's
ability to dispose of the underlying securities. As of March 31, 2024, the Fund had an investment in a repurchase agreement
for which the value of the
related collateral exceeded the value of the repurchase agreement.
|
|
ADR
|
An American Depositary Receipt is a certificate issued by a custodian bank representing the right to receive securities of
the foreign issuer described.
The values of ADRs may be significantly influenced by trading on exchanges not located in the United States.
|
|
Asset Valuation Inputs
|
||||
|
Description
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
Common Stocks
|
|
|
|
|
|
Australia
|
$ —
|
$1,860,086
|
$ —
|
$1,860,086
|
|
Belgium
|
—
|
704,373
|
—
|
704,373
|
|
China
|
5,458,802
|
2,557,874
|
—
|
8,016,676
|
|
Denmark
|
—
|
3,038,796
|
—
|
3,038,796
|
|
France
|
—
|
1,585,123
|
—
|
1,585,123
|
|
Germany
|
—
|
1,554,246
|
—
|
1,554,246
|
|
Japan
|
—
|
1,206,385
|
—
|
1,206,385
|
|
Macau
|
—
|
256,381
|
—
|
256,381
|
|
Netherlands
|
268,439
|
2,624,918
|
—
|
2,893,357
|
|
Switzerland
|
639,205
|
1,069,510
|
—
|
1,708,715
|
|
United Kingdom
|
—
|
1,820,778
|
—
|
1,820,778
|
|
United States
|
4,515,077
|
3,103,688
|
—
|
7,618,765
|
|
All Other Common Stocks(a)
|
4,610,896
|
—
|
—
|
4,610,896
|
|
Total Common Stocks
|
15,492,419
|
21,382,158
|
—
|
36,874,577
|
|
Short-Term Investments
|
—
|
659,698
|
—
|
659,698
|
|
Total Investments
|
$15,492,419
|
$22,041,856
|
$—
|
$37,534,275
|
|
(a)
|
Details of the major categories of the Fund’s investments are reflected within the Portfolio of Investments.
|
|
Industry Summary at March 31, 2024 (Unaudited)
|
|
|
Pharmaceuticals
|
13.4%
|
|
Broadline Retail
|
9.6
|
|
Financial Services
|
9.4
|
|
Software
|
9.0
|
|
Beverages
|
9.0
|
|
Hotels, Restaurants & Leisure
|
8.7
|
|
Semiconductors & Semiconductor Equipment
|
7.8
|
|
Interactive Media & Services
|
5.3
|
|
Automobiles
|
3.7
|
|
IT Services
|
3.2
|
|
Professional Services
|
3.0
|
|
Food Products
|
2.8
|
|
Household Products
|
2.7
|
|
Machinery
|
2.6
|
|
Health Care Equipment & Supplies
|
2.1
|
|
Other Investments, less than 2% each
|
5.6
|
|
Short-Term Investments
|
1.7
|
|
Total Investments
|
99.6
|
|
Other assets less liabilities
|
0.4
|
|
Net Assets
|
100.0%
|